EE333 Analysis of the Cost of Managing Patients with Advanced or Metastatic Non-Small Cell Lung Cancer in Argentina: Lorlatinib VS Alectinib

Jul 1, 2022, 00:00 AM
10.1016/j.jval.2022.04.578
https://www.valueinhealthjournal.com/article/S1098-3015(22)00779-3/fulltext
Section Title :
Section Order : 10519
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00779-3&doi=10.1016/j.jval.2022.04.578
HEOR Topics :
Tags :
Regions :